Related Experiment Video
Updated: May 19, 2026

06:15
Anterior High-Resolution Optical Coherence Tomography in the Diagnosis and Therapeutic Monitoring of Ocular Surface Squamous Neoplasia
Published on: August 9, 2024
[Pure primary breast squamous cell carcinoma]
Pedro Manso1, Cátia Carnide, Joana Raposo
1Serviço de Ginecologia, Centro Hospitalar de Coimbra, Coimbra, Portugal.
Acta Medica Portuguesa
|August 4, 2012
Summary
Pure primary breast squamous cell carcinoma is a rare and aggressive cancer. This case report reviews diagnostic criteria, features, and treatment for this challenging breast malignancy.
Area of Science:
- Oncology
- Pathology
- Surgical Oncology
Background:
- Pure and primary breast squamous cell carcinoma is an exceptionally rare breast malignancy, accounting for less than 0.1% of all breast cancers.
- Accurate diagnosis requires strict histologic and clinical criteria to differentiate it from other squamous lesions and metastatic cancers.
- This aggressive tumor type is often refractory to treatment and carries a poorer prognosis compared to non-squamous breast tumors.
Observation:
- The authors report a case of a patient diagnosed with pure primary breast squamous cell carcinoma.
- The case involved a comprehensive review of existing literature concerning diagnostic standards, characteristic features, origins, outlook, and treatment strategies.
Findings:
- The study emphasizes the rarity and aggressive nature of primary breast squamous cell carcinoma.
- Diagnostic challenges include distinguishing it from squamous differentiation in ductal carcinoma, skin-originated squamous tumors, and metastatic disease.
- The review covers essential aspects from morphology to therapeutic interventions.
Implications:
- Improved understanding of diagnostic criteria can lead to earlier and more accurate detection of this rare breast cancer.
- Knowledge of histogenesis and prognostic factors can guide treatment decisions for better patient outcomes.
- This review provides a valuable resource for clinicians managing patients with primary breast squamous cell carcinoma.
